Who backs Vanqua Bio?
12 investors| Investor | Type |
|---|---|
| OrbiMed | Growth equity |
| Osage University Partners | Venture capital |
| Casdin Capital | Venture capital |
| Logos Capital | Hedge fund |
| Omega Funds | PE / buyout |
| Surveyor Capital | Hedge fund |
| Avoro Capital | — |
| Eli Lilly | — |
| Northwestern University | — |
| Pontifax Venture Capital | — |
| + 2 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Vanqua Bio investors
12 investors are on record for Vanqua Bio, including OrbiMed, Osage University Partners, Casdin Capital and Logos Capital. By type, the record holds 2 venture capital firms, 2 hedge funds and 1 private equity firm. The early-stage round in Feb 2024 drew 12 investors.
Free account
More of Vanqua Bio with a free account
- ·The complete investor list: 12 names
- ·Watch Vanqua Bio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Vanqua Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View